Citation: | CAILin-ling, FANGLi-wen, LIUZi-xiu. Effect of Hedan Tiaozhi Recipe on Lipid Metabolites in Mice[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 365-369. |
[1] |
REINER E. Hypertriglyceridaemia and risk of coronary artery disease [J].Nat Rev Cardiol, 2017,14: 401-411.
|
[2] |
杨永革,王占庆,姜楠,等.他汀类药物的不良反应[J].医药导报,2011,30(6):817-820.
|
[3] |
吴娜琼,徐瑞霞,李莎,等.荷丹片对高脂血症患者血脂谱、PCSK9水平及高密度脂蛋白颗粒的影响[J].中国动脉硬化杂志,2015,23(12):1277-1280.
|
[4] |
张淑丽,王怡萍,杜振霞,等.基于UPLC-/TOF-MS技术的果糖诱导高尿酸血症大鼠血清脂质代谢组学研究[J].中国中药杂志,2016,41(6):1135-1139.
|
[5] |
杜丽娜,单进军,谢彤,等.基于液相质谱联用的黄芩水提液抗病毒效应的脂质组学研究[J].中华中医药杂志,2015,30(5):1728-1733.
|
[6] |
成玉,刘玉敏,黄凤杰,等.基于超高效液相色谱-四极杆飞行时间高分辨质谱的高通量血清代谢组学方法[J].高等学校化学学报,2013,34(1):77-83.
|
[7] |
曹栋,裘爱泳,王兴国.磷脂及磷脂酰胆碱生物学功能[J]. 粮食与油脂, 2002,(11):23-24.
|
[8] |
POLONCOVA K, GRIAC P. Phospholipid transport and remodeling in health and disease [J]. Gen Physiol Biophys, 2011, 30(5):25-35.
|
[9] |
中国胆固醇教育计划委员会. 高甘油三酯血症及其心血管风险管理专家共识[J].中华心血管病杂志, 2017, 45(2):108.
|
[10] |
XU R, WU N, SHA L, et al. Effects of Hedan Tablet on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary study [J]. Chin J Integr Med, 2016, 22(9):1-6.
|